Calcium Antagonists for Identification of Mechanisms and Treatment in Patients with Essential Hypertension

[1]  J. Laragh,et al.  Frontiers in Hypertension Research , 2011, Springer New York.

[2]  P. Erne,et al.  Platelet membrane Ca(2+)-ATPase: blunted calmodulin-stimulation in essential hypertension. , 1985, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[3]  P. Erne,et al.  Adrenaline induces vasoconstriction through post-junctional alpha 2 adrenoceptors and this response is enhanced in patients with essential hypertension. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[4]  M. Vallotton,et al.  Cytosolic free calcium and intracellular calcium stores are normal in neutrophils from patients with essential hypertension. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[5]  P. Erne,et al.  Free calcium response to adrenaline in platelets of normal and hypertensive (untreated and treated) subjects. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[6]  B. Robinson.  Altered calcium handling as a cause of primary hypertension. , 1984, Journal of hypertension.

[7]  P. Erne,et al.  Correlation of platelet calcium with blood pressure. Effect of antihypertensive therapy. , 1984, The New England journal of medicine.

[8]  S. Orlov,et al.  Cell membrane alteration as a source of primary hypertension. , 1984, Journal of hypertension.

[9]  S. Orlov,et al.  Calcium transport in synaptosomes and subcellular membrane fractions of brain tissue in spontaneously hypertensive rats. , 1983, Clinical science.

[10]  P. Erne,et al.  Factors influencing the hypotensive effects of calcium antagonists. , 1983, Hypertension.

[11]  H. Reuter.  Calcium channel modulation by neurotransmitters, enzymes and drugs , 1983, Nature.

[12]  T. Itoh,et al.  Factors modifying contraction-relaxation cycle in vascular smooth muscles. , 1982, The American journal of physiology.

[13]  F. Bühler,et al.  Enhanced vasodilatation in essential hypertension by calcium channel blockade with verapamil. , 1982 .

[14]  R. Landmann,et al.  High affinity beta-2-adrenergic receptors in mononuclear leucocytes: similar density in young and old normal subjects. , 1981, Life sciences.

[15]  M. Devynck,et al.  Analysis of Calcium Handling in Erythrocyte Membranes of Genetically Hypertensive Rats , 1981, Hypertension.

[16]  P. Bolli,et al.  Enhanced Alpha‐Adrenoreceptor‐Mediated Vasoconstriction in Essential Hypertension , 1981, Hypertension.

[17]  F. Bühler,et al.  Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. , 1981, Clinical science.

[18]  R. A. Norman,et al.  Continuous Monitoring of Arterial Pressure Indicates Sinoaortic Denervated Rats Are Not Hypertensive , 1981, Hypertension.

[19]  G. L. Le Breton,et al.  Epinephrine induces Ca2+ uptake in human blood platelets. , 1980, The American journal of physiology.

[20]  R. Bonow,et al.  Relative Effects of Sulfinpyrazone and Ibuprofen on Canine Platelet Function and Prostaglandin‐Mediated Coronary Vasodilation , 1980, Journal of cardiovascular pharmacology.

[21]  O. Bertel,et al.  Decreased Beta‐Adrenoreceptor Responsiveness as Related to Age, Blood Pressure, and Plasma Catecholamines in Patients with Essential Hypertension , 1980, Hypertension.

[22]  F. Bühler,et al.  Antihypertensive Response to Postsynaptic &agr;‐Blockade with Prazosin in Low‐ and Normal‐Renin Hypertension , 1980 .

[23]  P Meyer,et al.  Increased plasma adrenaline concentrations in benign essential hypertension. , 1977, British medical journal.

[24]  P. Sever,et al.  PLASMA-NORADRENALINE IN ESSENTIAL HYPERTENSION , 1977, The Lancet.

[25]  S. Julius,et al.  Mild high-renin essential hypertension. Neurogenic human hypertension? , 1977, The New England journal of medicine.

[26]  I. Kopin,et al.  Age-adjusted plasma norepinephrine levels are similar in normotensive and hypertensive subjects. , 1977, The New England journal of medicine.

[27]  M. Safar,et al.  Isoproterenol Sensitivity and Total Body Clearance of Propranolol in Hypertensive Patients , 1976, Journal of clinical pharmacology.

[28]  P. Hamet,et al.  Contrasting Effects of Hypoglycemia on Plasma Renin Activity and Cyclic Adenosine 3′, 5‐Monophosphate (Cyclic AMP) in Low Renin and Normal Renin Essential Hypertension , 1976, Circulation research.

[29]  M. Pfisterer,et al.  Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension. , 1975, The American journal of cardiology.

[30]  T. Pollard,et al.  Human platelet myosin. II. In vitro assembly and structure of myosin filaments , 1975, The Journal of cell biology.

[31]  J. Laragh,et al.  Renin Subgroups in Essential Hypertension: FURTHER ANALYSIS OF THEIR PATHOPHYSIOLOGICAL AND EPIDEMIOLOGICAL CHARACTERISTICS , 1973, Circulation research.

[32]  J. Laragh,et al.  Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. , 1972, The New England journal of medicine.

[33]  P. Timmermans,et al.  Postjunctional α‐Adrenoceptors and the Regulation of Arteriolar Tone in Humans , 1985 .

[34]  F. Bühler,et al.  The place of the calcium antagonist verapamil in antihypertensive therapy. , 1982, Journal of cardiovascular pharmacology.

[35]  F. Follath,et al.  Serum concentration and antihypertensive effect of slow-release verapamil. , 1982, Journal of cardiovascular pharmacology.

[36]  J. Laragh,et al.  Renin subgroups in essential hypertension. , 1982, Clinical and experimental hypertension. Part A, Theory and practice.

[37]  F. Bühler,et al.  Role of alpha-adrenoceptor-mediated vasoconstriction for antihypertensive beta-blockade. , 1982, Journal of cardiovascular pharmacology.

[38]  Y. Postnov.  Alteration of Cell Membrane Control over Intracellular Calcium in Essential Hypertension and in Spontaneously Hypertensive Rats , 1981 .

[39]  F. Bühler,et al.  Elevated plasma adrenaline reflects sympathetic overactivity and enhanced alpha-adrenoceptor-mediated vasoconstriction in essential hypertension. , 1981, Clinical science.

[40]  J. Champlain.  Use of Circulating Catecholamines for the Detection of Autonomic Abnormalities in Human Hypertension , 1981 .

[41]  M. Devynck,et al.  Calcium binding alteration in plasma membrane from various tissues of spontaneously hypertensive rat. , 1981, Clinical and experimental hypertension.

[42]  J. Fleisch.  Age-related changes in the sensitivity of blood vessels to drugs. , 1980, Pharmacology & therapeutics.

[43]  S. Orlov,et al.  Calcium accumulation and calcium binding by the cell membranes of cardiomyocytes and smooth muscle of aorta in spontaneously hypertensive rats. , 1980, Clinical science.

[44]  E. Daniel,et al.  Abnormal biochemistry of vascular smooth muscle plasma membrane isolated from hypertensive rats. , 1980, Molecular pharmacology.

[45]  R. Landmann,et al.  Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjects. , 1980, Clinical and experimental hypertension.

[46]  M. Pfisterer,et al.  Haemodynamic responses to exercise and acute beta-receptor blockade in renin sub-types of essential hypertension. , 1976, Clinical science and molecular medicine. Supplement.

[47]  M. Blaustein.  The interrelationship between sodium and calcium fluxes across cell membranes. , 1974, Reviews of physiology, biochemistry and pharmacology.

[48]  P. Åstrand,et al.  Textbook of Work Physiology , 1970 .